{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:08:27Z","timestamp":1767838107248,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12094-014-1237-z","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T06:50:13Z","timestamp":1412837413000},"page":"358-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"X.","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(96)07185-1","volume":"349","author":"NH Russell","year":"1997","unstructured":"Russell NH. Biology of acute leukaemia. Lancet. 1997;349:118\u201322.","journal-title":"Lancet"},{"key":"1237_CR2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"1237_CR3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.23404","volume":"88","author":"EH Estey","year":"2013","unstructured":"Estey EH. Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol. 2013;88:318\u201327.","journal-title":"Am J Hematol"},{"key":"1237_CR4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1345\/aph.1R151","volume":"46","author":"A Ganetsky","year":"2012","unstructured":"Ganetsky A. The role of decitabine for the treatment of acute myeloid leukemia. Ann Pharmacother. 2012;46:1511\u20137.","journal-title":"Ann Pharmacother"},{"key":"1237_CR5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pbc.24464","volume":"60","author":"SE Puumala","year":"2013","unstructured":"Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013;60:728\u201333.","journal-title":"Pediatr Blood Cancer"},{"key":"1237_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pbc.23279","volume":"58","author":"AA Danen-van Oorschot","year":"2012","unstructured":"Danen-van Oorschot AA, Kuipers JE. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2012;58:715\u201321.","journal-title":"Pediatr Blood Cancer"},{"key":"1237_CR7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14712598.2012.671293","volume":"12","author":"X Liu","year":"2012","unstructured":"Liu X, Liu L, Xu Q. MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Ther. 2012;12:573\u201380.","journal-title":"Expert Opin Biol Ther"},{"key":"1237_CR8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non coding RNAs in human disease. Nat Rev Genet. 2011;12:861\u201374.","journal-title":"Nat Rev Genet"},{"key":"1237_CR9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc3107","volume":"11","author":"M Kouwenhove van","year":"2011","unstructured":"van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644\u201356.","journal-title":"Nat Rev Cancer"},{"key":"1237_CR10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590\u2013610.","journal-title":"Mol Oncol"},{"key":"1237_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.2012.192","volume":"93","author":"SP Nana-Sinkam","year":"2013","unstructured":"Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther. 2013;93:98\u2013104.","journal-title":"Clin Pharmacol Ther"},{"key":"1237_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"1237_CR13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.4161\/cc.7.16.6453","volume":"7","author":"PP Medina","year":"2008","unstructured":"Medina PP, Slack FJ. microRNAs and cancer: an overview. Cell Cycle. 2008;7:2485\u201392.","journal-title":"Cell Cycle"},{"key":"1237_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2012.09.002","volume":"46","author":"C Zhu","year":"2013","unstructured":"Zhu C, Wang Y, Kuai W. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin Biochem. 2013;46:49\u201353.","journal-title":"Clin Biochem"},{"key":"1237_CR15","doi-asserted-by":"crossref","first-page":"e56718","DOI":"10.1371\/journal.pone.0056718","volume":"8","author":"F Zhi","year":"2013","unstructured":"Zhi F, Cao X, Xie X. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One. 2013;8:e56718.","journal-title":"PLoS One"},{"key":"1237_CR16","doi-asserted-by":"crossref","unstructured":"Croce CM. MicroRNA dysregulation in acute myeloid leukemia. J Clin Oncol. 2013;31:2065\u20136.","DOI":"10.1200\/JCO.2013.48.8239"},{"key":"1237_CR17","doi-asserted-by":"crossref","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","volume":"4","author":"H Zhang","year":"2009","unstructured":"Zhang H, Luo XQ, Zhang P. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One. 2009;4:e7826.","journal-title":"PLoS One"},{"key":"1237_CR18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1101\/gad.1974211","volume":"25","author":"KJ Png","year":"2011","unstructured":"Png KJ, Yoshida M, Zhang XH. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 2011;25:226\u201331.","journal-title":"Genes Dev"},{"key":"1237_CR19","doi-asserted-by":"crossref","first-page":"e40037","DOI":"10.1371\/journal.pone.0040037","volume":"7","author":"Z Yan","year":"2012","unstructured":"Yan Z, Xiong Y, Xu W. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012;7:e40037.","journal-title":"PLoS One"},{"key":"1237_CR20","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/ijc.25962","volume":"129","author":"H Heyn","year":"2011","unstructured":"Heyn H, Engelmann M, Schreek S. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011;129:2797\u2013806.","journal-title":"Int J Cancer."},{"key":"1237_CR21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1309\/AJCPLYTZGB54ISZC","volume":"141","author":"J Cao","year":"2014","unstructured":"Cao J, Cai J, Huang D. miR-335 Represents an independent prognostic marker in epithelial ovarian cancer. Am J Clin Pathol. 2014;141:437\u201342.","journal-title":"Am J Clin Pathol"},{"key":"1237_CR22","first-page":"1625","volume":"6","author":"HH Peng","year":"2013","unstructured":"Peng HH, Zhang YD, Gong LS. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther. 2013;6:1625\u201330.","journal-title":"Onco Targets Ther."},{"key":"1237_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-013-1786-4","volume":"384","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhao W, Fu Q. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013;384:105\u201311.","journal-title":"Mol Cell Biochem"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1237-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1237-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1237-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:51:42Z","timestamp":1559447502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1237-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1237-z","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]}}}